![[HTML version]](/e/graphics/htmlborder.gif)
![[PDF version]](/e/graphics/pdfborder.gif)
![[CIF]](/e/graphics/cifborder.gif)
![[3d view]](/e/graphics/3dviewborder.gif)
![[Structure Factors]](/e/graphics/structurefactorsborder.gif)
![[Supplementary Material]](/e/graphics/supplementarymaterialsborder.gif)
![[CIF check Report]](/e/graphics/checkcifborder.gif)
![[Open access]](/e/graphics/free.gif)
![[Contents scheme]](ng2576contents.gif)
Acta Cryst. (2009). E65, m705 [ doi:10.1107/S1600536809019783 ]
2O,O')[(6R,8R)-(-)-7,7-dimethyl-3-(2-pyridyl)-5,6,7,8-tetrahydro-6,8-methanoisoquinoline-
2N,N']terbium(III)Abstract: In the title compound, [Tb(C15H11O2)3(C17H18N2)], the 7,7-dimethyl-3-(2-pyridyl)-5,6,7,8-tetrahydro-6,8-methanoisoquinoline (LRR) ligand coordinates to TbIII through the two N atoms of the heterocycle. The metal centre is also chelated by three deprotonated 1,3-diphenylpropane-1,3-dione (dbm) ligands, forming enantiomerically pure [Tb(dbm)3LRR]. The TbIII atom is located in a distorted square antiprism of eight coordinating atoms (six O and two N atoms).
Online 6 June 2009
Copyright © International Union of Crystallography
IUCr Webmaster